Isabelle Barber is Appointed to ExonHit Therapeutics SA Management Board
9/7/2011 10:10:09 AM
More...
|
ExonHit Therapeutics SA Announces Successful Completion of the First Phase of EHT Dx14 Ongoing Clinical Validation
3/30/2011 10:57:20 AM
More...
|
Selcia Limited and ExonHit Therapeutics SA Announce Successful Fragment Screening Collaboration
2/28/2011 9:09:53 AM
More...
|
RedPath Integrated Pathology, Inc. Terminates Deal with ExonHit Therapeutics SA
10/27/2010 10:11:42 AM
More...
|
ExonHit Therapeutics SA Announces the Holding of an Extraordinary Shareholders' Meeting to Approve the Acquisition of RedPath Integrated Pathology, Inc.
5/26/2010 11:15:26 AM
More...
|
RedPath Integrated Pathology, Inc. Acquired By ExonHit Therapeutics SA
4/26/2010 11:58:54 AM
More...
|
ExonHit Therapeutics SA Receives "Innovative Company" Accreditation from the French State Innovation Agency OSEO
4/6/2010 9:39:43 AM
More...
|
ExonHit Therapeutics SA Reports out-Licensing of EHT/AGN 0001 by Allergan Inc. (AGN) to Bristol-Myers Squibb Company (BMY)
3/3/2010 10:36:23 AM
More...
|
French ExonHit Therapeutics SA to Buy U.S. Diagnostics Firm
12/8/2009 7:32:06 AM
More...
|
ExonHit Therapeutics SA Raises EUR 1.45 Million Through the Exercise of Warrants
7/8/2009 9:26:52 AM
More...
|
|